Find your next paid study

University of California, IrvineNCT07568756

Actual pay is set by the research site.

Observational

Rural Autistic Individuals - Supporting Expression

This research study investigates how hand gestures can support language comprehension and communication skills of hearing speaking, non-speaking, and/or minima…

Autism DisorderLanguage Development DisordersADHD+7 more

Montana State UniversityNCT07054866

~$10 – $750

Actual pay is set by the research site.

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Locally Advanced Unresectable HER2-Negative Breast Carcinoma+3 more

A Phase II Trial to Evaluate Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

This phase II trial tests the accuracy of functional imaging (FFNP)-positron emission tomography (PET)/computed tomography (CT) to predict response to abemacic…

Actual pay is set by the research site.

University of Washington

Hidradenitis Suppurativa (HS)

Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa

This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chronic inflammatory skin disease hidradeni…

University of Massachusetts, WorcesterNCT07756346

Actual pay is set by the research site.

Advanced Integrative Oncology Treatment for Adult and Pediatric Patients With Cancer: A Prospective Outcomes Study

The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cance…

NeoplasmsNeoplasm MalignantAdvanced Cancer+2 more

Advanced Integrative Medical Science InstituteNCT04495790

~$10 – $1,125

Actual pay is set by the research site.

POst-Market ClINical Follow-up STudy oF the SerranatOR PTA Serration Balloon CathEter

The objective of this registry is to collect observational data under local standard of care and evaluate safety and performance of the Serranator® in treatmen…

Peripheral Artery Disease (PAD)Dysfunctional AV FistulaDysfunctional AV Graft

Cagent Vascular LLCNCT06687590

~$10 – $1,050

Actual pay is set by the research site.

Phase 1

Phase I Clinical Trial of CA-4948 (Emavusertib) in Combination With FOLFOX Plus Bevacizumab as Frontline Treatment in Patients With Metastatic Colorectal Cancer

This phase I trial studies the side effects and best dose of CA-4948 when given together with fluorouracil, leucovorin, oxaliplatin (FOLFOX) plus bevacizumab i…

Metastatic Colorectal AdenocarcinomaStage III Colorectal Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8+1 more

National Cancer Institute (NCI)NCT06696768

~$150 – $2,700

Actual pay is set by the research site.

Lung CancerNon-small Cell Lung CancerMetastatic Lung Cancer+4 more

Timing of Immunotherapy and Effective Administration (TIMED): Effects of Infusion Timing on Treatment Response in Solid Tumors

This study evaluates whether the time of day when immunotherapy is given affects clinical outcomes. It includes patients eligible for PD-1 (programmed cell dea…

UNC Lineberger Comprehensive Cancer CenterNCT07630168

Actual pay is set by the research site.

Phase 1

A Phase Ia/Ib, 2-Part, Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors

This is a study that will enroll patients with cancer who have tumors that may have spread. The patients will know what medication they are being given. There…

Solid TumorAdvanced Solid TumorMetastatic Solid Tumor

Pancreatic Ductal Adenocarcinoma

~$150 – $4,500

Actual pay is set by the research site.

Lei ZhengNCT07086768

Phase 1

A Phase 1b Study of Neoadjuvant ASP2138 Monotherapy and Investigator's Choice of Adjuvant Chemotherapy in Participants With Resectable Pancreatic Ductal Adenocarcinoma Whose Tumors Have Claudin (CLDN) 18.2 Expression

Some people with pancreatic ductal cancer (PDAC) have a protein called Claudin 18.2 (CLDN18.2) in their tumor. ASP2138 is thought to work by binding to CLDN18.…

Astellas Pharma Global Development, Inc.NCT07024615

~$150 – $4,200

Actual pay is set by the research site.

Colorectal CancerGastric CancersOvarian Cancers+1 more

A Phase 2/3, Multicenter, Open-Label, Non-Randomized Study to Evaluate Diagnostic Performance of GEH300079 (68Ga) Injection Positron-Emission Tomography (PET)/Computed Tomography (CT) for Detection of Peritoneal Carcinomatosis (PC) in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

This study is a Phase 2/3, prospective, multicenter, open-label, non-randomized clinical trial, in which GEH300079 (68Ga) PET/CT images will be acquired in pat…

Bladder CancerNon-muscle-invasive Bladder CancerMuscle-Invasive Bladder Carcinoma

~$75 – $3,000

Actual pay is set by the research site.

GE HealthcareNCT07219238

Observational

Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)

The PRIMER (Pre-Habilitation With Mindfulness and Exercise for Patients Undergoing Radical Cystectomy) trial is a pilot designed to estimate the feasibility of…